SurModics Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $35.45
- Today's High:
- $38.29
- Open Price:
- $38.23
- 52W Low:
- $16
- 52W High:
- $39.41
- Prev. Close:
- $38.25
- Volume:
- 45002
Company Statistics
- Market Cap.:
- $540.63 million
- Book Value:
- 7.953
- Revenue TTM:
- $130.60 million
- Operating Margin TTM:
- 1.11%
- Gross Profit TTM:
- $29 million
- Profit Margin:
- -17.58%
- Return on Assets TTM:
- 0.5%
- Return on Equity TTM:
- -19.33%
Company Profile
SurModics Inc had its IPO on 1998-03-04 under the ticker symbol SRDX.
The company operates in the Healthcare sector and Medical Devices industry. SurModics Inc has a staff strength of 447 employees.
Stock update
Shares of SurModics Inc opened at $38.23 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $35.45 - $38.29, and closed at $35.53.
This is a -7.11% slip from the previous day's closing price.
A total volume of 45,002 shares were traded at the close of the day’s session.
In the last one week, shares of SurModics Inc have slipped by -1.85%.
SurModics Inc's Key Ratios
SurModics Inc has a market cap of $540.63 million, indicating a price to book ratio of 4.6631 and a price to sales ratio of 5.0527.
In the last 12-months SurModics Inc’s revenue was $130.60 million with a gross profit of $29 million and an EBITDA of $10.05 million. The EBITDA ratio measures SurModics Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, SurModics Inc’s operating margin was 1.11% while its return on assets stood at 0.5% with a return of equity of -19.33%.
In Q2, SurModics Inc’s quarterly earnings growth was a positive 435.8% while revenue growth was a positive 111.2%.
SurModics Inc’s PE and PEG Ratio
- Forward PE
- 81.9672
- Trailing PE
- 0
- PEG
- 3.8952
Its diluted EPS in the last 12-months stands at $-1.68 per share while it has a forward price to earnings multiple of 81.9672 and a PEG multiple of 3.8952. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SurModics Inc’s profitability.
SurModics Inc stock is trading at a EV to sales ratio of 5.0149 and a EV to EBITDA ratio of -39.3043. Its price to sales ratio in the trailing 12-months stood at 5.0527.
SurModics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $188.90 million
- Total Liabilities
- $32.05 million
- Operating Cash Flow
- $-470000.00
- Capital Expenditure
- $470000
- Dividend Payout Ratio
- 0%
SurModics Inc ended 2024 with $188.90 million in total assets and $0 in total liabilities. Its intangible assets were valued at $188.90 million while shareholder equity stood at $112.41 million.
SurModics Inc ended 2024 with $5.55 million in deferred long-term liabilities, $32.05 million in other current liabilities, 707000.00 in common stock, $80.56 million in retained earnings and $43.84 million in goodwill. Its cash balance stood at $44.58 million and cash and short-term investments were $44.58 million. The company’s total short-term debt was $1,046,000 while long-term debt stood at $29.35 million.
SurModics Inc’s total current assets stands at $85.85 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $23.70 million compared to accounts payable of $2.48 million and inventory worth $14.61 million.
In 2024, SurModics Inc's operating cash flow was $-470000.00 while its capital expenditure stood at $470000.
Comparatively, SurModics Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $35.53
- 52-Week High
- $39.41
- 52-Week Low
- $16
- Analyst Target Price
- $54.75
SurModics Inc stock is currently trading at $35.53 per share. It touched a 52-week high of $39.41 and a 52-week low of $39.41. Analysts tracking the stock have a 12-month average target price of $54.75.
Its 50-day moving average was $34.22 and 200-day moving average was $28.16 The short ratio stood at 1.9 indicating a short percent outstanding of 0%.
Around 377.3% of the company’s stock are held by insiders while 8915.9% are held by institutions.
Frequently Asked Questions About SurModics Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.